Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)

Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie, David E. Gerber

Internal Medicine
Endocrinology
Simmons Comprehensive Cancer Center
Ctr-Simmons Compr. Cancer
Bioinformatics
SPH-Data Sciences in Precision
Bioinformatics
Peter O'Donnell Jr. School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)

Fingerprint

Medicine & Life Sciences